Conditions
After cancer treatment
Radiotherapy, chemotherapy, stem-cell transplant and immunotherapy each leave something different behind in the mouth and the body — and a patient who says the cancer is finished may still be carrying most of it.
A patient who has finished cancer treatment is not a patient without a cancer history, and what each treatment leaves behind is different enough that the useful first question is which treatment, to which field, when, and what is still running. Head and neck radiotherapy leaves dry mouths, caries in roughly three in ten patients on pooled and very heterogeneous data, trismus that peaks around six months and persists in about a third, and bone that heals poorly for life, with the 2024 ISOO-MASCC-ASCO guideline finding hyperbaric oxygen largely unjustified for preventing or managing osteoradionecrosis. Chemotherapy and transplant leave windows of low counts that decide when surgery can be done, chronic graft-versus-host disease in the mouth after allogeneic transplant, and a seven- to sixteen-fold higher reported risk of secondary oral cancer in allogeneic recipients; checkpoint inhibitors can cause lichenoid, dry-mouth and blistering reactions that are adverse drug events to report rather than local problems. A systematic review found no clinical trials and no documented cases linking dental procedures to infection of an indwelling central line, the AHA endocarditis statement does not cover lines, and anthracyclines leave clinically overt cardiotoxicity in about 6% and subclinical changes in about 18% of treated patients over long follow-up, which matters for sedation and epinephrine years after the chemotherapy ended. The connecting thread is liaison: the oncology team holds information about counts, fields, drugs and timing that the dental plan cannot be made without.
The rest of this piece is for clinicians
Full pieces are open to registered dentists. Registration takes a moment and there is no mailing list attached to it.
This piece is education for clinicians, not advice for any patient. It describes conditions, precautions and the reasoning behind decisions at the level of the condition; it does not give step-by-step operative technique, and it is not a substitute for the judgement of the treating clinician, the patient's physicians, or the guidance of the relevant professional bodies. Reading it creates no clinician–patient or consulting relationship, and nothing here is direction to any reader about a patient in front of them.
Drug doses, maximums and formulations change and differ between references and package inserts — verify every figure against a current primary source before you rely on it. Where a position here differs from current product labelling that is stated in the text, and the labelling, not this page, is the reference. Guidance cited is drawn from several countries and professional bodies; which applies to you is a question for your own regulator and permit. Passages describing occupational exposure, equipment or staffing are general background rather than an occupational-health assessment of any workplace.